[Effect of suppressive and activating glycoconjugates on lymphocytes].
B B
BB
Fuks
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D000970:Antineoplastic Agents; D003470:Culture Media; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli; D006801:Humans; D007166:Immunosuppressive Agents; D066298:In Vitro Techniques; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D003470:Culture Media; D007166:Immunosuppressive Agents; D008070:Lipopolysaccharides; D000119:Acetylmuramyl-Alanyl-Isoglutamine
Deĭstvie supressornykh i aktiviruiushchikh glikokon'' iugatov na limfotsity.